METHOD FOR TREATING CHLAMYDIA-CAUSED PROSTATITIS CASES Russian patent published in 2007 - IPC A61K31/7048 A61K38/21 A61K31/185 A61K31/245 A61P13/08 A61N5/67 A61H19/00 

FIELD: medicine.

SUBSTANCE: method involves administering combined therapy. Azythromycin is introduced at a dose of 1 g once a week as etiotropic therapy during 3 weeks. Ten rectal laser radiation treatment sessions are given beginning from the third combined treatment day. Γ-interferon, interleukin 1β, interleukin 4, interleukin 6 and lactoferrin human blood serum concentrations are additionally measured. Γ-interferon concentration becoming less than 45 IU/ml, that of interleukin 1β growing above 50 pg/ml, interleukin 4 greater than 45 pg/ml, interleukin 6 greater than 60 pg/l and lactoferrin greater than 300 ng/ml, rectal Henferon suppositories are introduced at a dose of 500000 IU twice a day during 14 days. The Henferon treatment course is repeated in 10 days. Ten prostate massage sessions are administered beginning from the twenty first combined therapy day.

EFFECT: enhanced effectiveness in eradicating pathologic agent; prevented infection recurrence; improved spermogram indices; accelerated treatment course; reduced risk of adverse side effects.